Novo Nordisk Completes Share Repurchase Program
Ticker: NONOF · Form: 6-K · Filed: Sep 30, 2024 · CIK: 353278
Sentiment: neutral
Topics: share-repurchase, capital-return
TL;DR
Novo Nordisk just finished buying back shares for ~500M DKK.
AI Summary
Novo Nordisk A/S announced on September 30, 2024, that it has completed its share repurchase program initiated on August 7, 2024. The company repurchased a total of 1,000,000 shares for a total cost of approximately DKK 500 million.
Why It Matters
This indicates the company is returning capital to shareholders, which can be a positive signal for investors.
Risk Assessment
Risk Level: low — This is a routine share repurchase announcement and does not introduce new material risks.
Key Numbers
- DKK 500 million — Share Repurchase Cost (Total amount spent on repurchasing shares.)
- 1,000,000 — Shares Repurchased (Number of shares bought back by the company.)
Key Players & Entities
- Novo Nordisk A/S (company) — Registrant
- DKK 500 million (dollar_amount) — Total cost of share repurchase
- August 7, 2024 (date) — Initiation date of share repurchase program
- September 30, 2024 (date) — Completion date of share repurchase program
- 1,000,000 (number) — Number of shares repurchased
FAQ
What was the total cost of the share repurchase program?
The total cost of the share repurchase program was approximately DKK 500 million.
How many shares did Novo Nordisk repurchase?
Novo Nordisk repurchased 1,000,000 shares.
When was the share repurchase program initiated?
The share repurchase program was initiated on August 7, 2024.
On what date was the completion of the share repurchase program announced?
The completion of the share repurchase program was announced on September 30, 2024.
Under which regulations was the share repurchase program conducted?
The share repurchase program was conducted in accordance with Article 5 of Regulation No 596/2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052.
Filing Stats: 627 words · 3 min read · ~2 pages · Grade level 10.1 · Accepted 2024-09-30 07:57:59
Filing Documents
- f6k_093024.htm (6-K) — 24KB
- logo.jpg (GRAPHIC) — 76KB
- ca.jpg (GRAPHIC) — 24KB
- 0001171843-24-005399.txt ( ) — 164KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf of the undersigned, thereunto duly authorized. Date: September 30, 2024 NOVO NORDISK A/S Lars Fruergaard Jørgensen Chief Executive Officer